Tinotenda Gwisai

Tinotenda Gwisai

Auto-generated profile, based on publicly available information

Tinotenda Gwisai

Institute for Translational Medicine, Department of Health Sciences and Technology, ETH Zurich, Zurich, Switzerland

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 October 2022 in Science Robotics
Verified
Journal Article
Closed access
TGT. Gwisai
T. Gwisai
NMN. Mirkhani
N. Mirkhani
MCM. G. Christiansen
M. G. Christiansen
TNT. T. Nguyen
T. T. Nguyen
VLV. Ling
V. Ling
Simone SchuerleSimone Schuerle
Simone Schuerle
Biohybrid bacteria–based microrobots are increasingly recognized as promising externally controllable vehicles for targeted cancer therapy. Magnetic fields in particular have been used as a safe means to transfer energy and direct their motion. Thus far, the magnetic control strategies used in this context rely on poorly scalable magnetic field gradients, require active position feedback, or are ill-suited to diffuse distributions within the body. Here, we present a magnetic torque–driven control scheme for enhanced transport through biological barriers that complements the innate taxis toward tumor cores exhibited by a range of bacteria, shown for Magnetospirillum magneticum as a magnetically responsive model organism. This hybrid control strategy is readily scalable, independent of position feedback, and applicable to bacterial microrobots dispersed by the circulatory system. We observed a fourfold increase in translocation of magnetically responsive bacteria across a model of the vascular endothelium and found that the primary mechanism driving increased transport is torque-driven surface exploration at the cell interface. Using spheroids as a three-dimensional tumor model, fluorescently labeled bacteria colonized their core regions with up to 21-fold higher signal in samples exposed to rotating magnetic fields. In addition to enhanced transport, we demonstrated that our control scheme offers further advantages, including the possibility for closed-loop optimization based on inductive detection, as well as spatially selective actuation to reduce off-target effects. Last, after systemic intravenous injection in mice, we showed significantly increased bacterial tumor accumulation, supporting the feasibility of deploying this control scheme clinically for magnetically responsive biohybrid microrobots.

9 March 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
NMNima Mirkhani
Nima Mirkhani
MCMichael G. Christiansen
Michael G. Christiansen
TGTinotenda Gwisai
Tinotenda Gwisai
SMStefano Menghini
Stefano Menghini
Simone SchuerleSimone Schuerle
Simone Schuerle
Rotating magnetic fields enable biomedical microrobots to overcome physiological barriers and promote extravasation and accumulation in tumors. Nevertheless, targeting deeply situated tumors requires suppression of off-target actuation in healthy tissue. Here, we investigate a control strategy for applying spatially selective torque density to microrobots by combining rotating fields with magnetostatic selection fields. Taking magnetotactic bacteria as diffuse torque-based actuators, we numerically model off-target torque suppression, indicating the feasibility of centimeter to millimeter resolution for human applications. We study focal torque application in vitro, observing off-target suppression of actuation-dependent effects such as colonization of bacteria in tumor spheroids. We then design and construct a mouse-scale torque-focusing apparatus capable of maneuvering the focal point. Applying this system to a mouse tumor model increased accumulation of intravenously injected bacteria within tumors receiving focused actuation compared to non-actuated or globally actuated groups. This control scheme combines the advantages of torque-based actuation with spatial targeting.

12 July 2017 in Biomedical Materials
Verified
Journal Article
Closed access
PDF file
TGTinotenda Gwisai
Tinotenda Gwisai
NHNisha Hollingsworth
Nisha Hollingsworth
SCSarah Cowles
Sarah Cowles
NTNagendran Tharmalingam
Nagendran Tharmalingam
EMEleftherios Mylonakis
Eleftherios Mylonakis
ASAnita Shukla
Anita Shukla
Device-associated and hospital-acquired infections remain amongst the greatest challenges in regenerative medicine. Furthermore, the rapid emergence of antibiotic resistance and lack of new classes of antibiotics has made the treatment of these bacterial infections increasingly difficult. The repurposing of Food and Drug Administration approved drugs for antimicrobial therapies is a powerful means of reducing the time and cost associated with drug discovery and development. In this work, niclosamide, a commercially available anthelmintic drug with recently identified antimicrobial properties, was found to prevent the formation of, and combat existing biofilms of, several relevant Gram-positive bacteria, namely strains of Staphylococcus aureus , including methicillin resistant S. aureus (MRSA), and Staphylococcus epidermidis , all common causes of hospital-acquired and device-associated infections. This anti-biofilm activity was demonstrated at niclosamide concentrations as low as 0.01 μ g ml −1 . We then assessed niclosamide activity as an antibacterial coating, which could potentially be applied to medical device surfaces. We developed solvent cast niclosamide coatings on a variety of surfaces common amongst medical devices including glass, titanium, stainless steel, and aluminum. Niclosamide-coated surfaces exhibited potent in vitro activity against S. aureus , MRSA, and S. epidermidis . At niclosamide surface concentrations as low as 1.6 × 10 −2 μ g mm −2 , the coatings prevented attachment of these bacteria. The coatings also cleared bacteria inoculated suspensions at niclosamide surface concentrations of 3.1 × 10 −2 μ g mm −2 . Hemolysis was not observed at any of the antimicrobial coating concentrations tested. We report a facile, effective means of coating devices with niclosamide to both clear and prevent biofilm formation of common bacteria encountered in hospital-acquired and device-associated infections.

10 January 2020 in ACS Synthetic Biology
Verified
Journal Article
Closed access
Simone SchuerleSimone Schuerle
Simone Schuerle
MFMaiko Furubayashi
Maiko Furubayashi
ASAva P. Soleimany
Ava P. Soleimany
TGTinotenda Gwisai
Tinotenda Gwisai
WHWei Huang
Wei Huang
SBSangeeta N. Bhatia
Sangeeta N. Bhatia

3 April 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
NMNima Mirkhani
Nima Mirkhani
MCMichael G. Christiansen
Michael G. Christiansen
TGTinotenda Gwisai
Tinotenda Gwisai
SMStefano Menghini
Stefano Menghini
Simone SchuerleSimone Schuerle
Simone Schuerle
Rotating magnetic fields (RMFs), when used to actuate biomedical microrobots for targeted delivery to tumors, have been shown to enable them to overcome physiological barriers and promote their accumulation and penetration into tissue. Nevertheless, directly applying a RMF to a deeply situated target site also leads to off-target actuation in surrounding healthy tissue. Here, we investigate an open-loop control strategy for delivering torque density to diffuse distributions of microrobots at focal points by combining RMFs with magnetostatic gating fields. Taking magnetotactic bacteria (MTB) as a model biohybrid microrobotic system for torque-based actuation, we first use simulation to elucidate off-target torque suppression and find that resolution is set by the relative magnitude of the magnetostatic field and RMF. We study focal torque delivery in vitro, observing off-target suppression of translational velocity of MTB, convection-driven accumulation of companion nanoparticles, and tumor spheroid colonization. We then design, construct, and validate a mouse-scale torque-focusing apparatus incorporating a permanent magnet array, three-phase RMF coils, and offset coils to maneuver the focal point. Our control scheme enables the advantages of torque-based actuation to be combined with spatial targeting, and could be broadly applied to other microrobotic designs for improved drug delivery. One-Sentence Summary: Combining rotating magnetic fields with gating fields enables focused delivery of torque density to dispersed microrobots.